Platelet activation, gamma-glutamyltransferase and stent restenosis. Comment on the article by Ulus et al.

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  Pompella, Alfonso ^a   Paolicchi, Aldo ^a   Emdin, Michele ^b   Mikhailidis, Dimitri P ^c  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Platelet activation; Serum gamma glutamyltransferase; Stent restenosis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ARTERY WALL; ATHEROGENESIS; CARDIOVASCULAR RISK; CORONARY STENT; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; RESTENOSIS; THROMBOCYTE ACTIVATION;

CD40 LIGAND; CONSTRICTION, PATHOLOGIC; CORONARY STENOSIS; GAMMA-GLUTAMYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PLATELET ACTIVATION; PROGNOSIS; STENTS;

EID: 35248849752     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.024     Document Type: Letter

References (12)

1. Ulus T, Yildirir A, Demirtas S, Demir O, Sade LE, Bozbas H, Gursoy Y, Bilgi M, Kucuk MA, Muderrisoglu H. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis. Atherosclerosis 2007, doi:10.1016/j.atherosclerosis.2006.09.025.
2. Pompella A., Emdin M., Passino C., and Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 42 (2004) 1085-1091
3. Emdin M., Passino C., Michelassi C., et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 22 (2001) 1802-1807
4. Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., and Ulmer H. Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiologic investigation in a cohort of 163, 944 Austrian adults. Circulation 112 (2005) 2130-2137
5. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyl transpeptidase-dependent iron reduction and low density lipoprotein oxidation-a potential mechanism in atherosclerosis. J Invest Med 47 (1999) 151-160
6. Paolicchi A., Emdin M., Passino C., et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186 (2006) 80-85
7. Emdin M., Pompella A., and Paolicchi A. Editorial-Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112 (2005) 2078-2080
8. Gurdol F., Nwose O.M., and Mikhailidis D.P. Gamma-glutamyltransferase activity in human platelets: quantification of activity, isoenzyme characterization and potential clinical relevance. Platelets 6 (1995) 200-203
9. Bolodeoku J.A., Ganotakis E.S., Mikhailidis D.P., and Winder A.F. Correlation between serum gamma-glutamyl transferase activity and the platelet count. Platelets 8 (1997) 333-335
10. Mitra A.K., and Agrawal D.K. In stent restenosis: bane of the stent era. J Clin Pathol 59 (2006) 232-239
11. Cheshire N.J.W., Wolfe J.H.N., Barradas M.A., Chambler A.W., and Mikhailidis D.P. Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis. Eur J Vasc Endovasc Surg 11 (1996) 479-486
12. Cipollone F., Ferri C., Desideri G., et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 108 (2003) 2776-2782